Update
$Tiziana Life Sciences(TLSA.US$ Tiziana Life Sciences Says Study Results From Intranasal Anti-CD3 Foralumab In Multiple Sclerosis Patients With PIRA Highlighted In Neurology Today! Says that treatment shows potential ![]()
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
